ADCT position history
The shares of Adc Therapeutics (ADCT) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q2: 204,081 shares, $645K, 0.15% of portfolio, New
- 2024 Q3: 204,081 shares, $643K, 0.15% of portfolio
- 2024 Q4: 224,081 shares, $446K, 0.11% of portfolio, Add +9.8%
- 2025 Q1: 224,081 shares, $316K, 0.09% of portfolio
- 2025 Q2: 122,081 shares, $327K, 0.09% of portfolio, Reduce −45.5%
- 2025 Q3: 122,081 shares, $488K, 0.12% of portfolio
- 2025 Q4: 77,081 shares, $272K, 0.06% of portfolio, Reduce −36.9%
- 2026 Q1: 72,081 shares, $270K, 0.06% of portfolio, Reduce −6.5%
- 2026 Q2: 77,081 shares, $82K, 0.02% of portfolio, Add +6.9%
- 2026 Q3: 57,081 shares, $70K, 0.01% of portfolio, Reduce −25.9%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|